Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 10, 2024
Reporting Period: First quarter ended March 31, 2024
This filing announces the issuance of a press release detailing financial results for the first quarter of 2024. A business update conference call was scheduled for May 10, 2024, at 8:30 am EST.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing serves as a notification of the results rather than a detailed financial statement.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors are directed to the attached press release (Exhibit 99.1) and the company website for detailed comparisons.
Guidance, Outlook, and Risks
Management Commentary: The Company announced a business update via conference call on the date of the filing.
Information Availability: Detailed materials are available on the Company's website at www.sanuwave.com/investors.
Legal Disclaimer: The information in Item 2.02 and the attached exhibit is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q1 2024 financial figures.
- Access the Company's investor website for the full business update materials.
- Verify the details of the conference call held on May 10, 2024, for management commentary on the results.
- Note that the 8-K text itself does not disclose specific financial metrics.